Skip to content
drillr.ai

TMCI

Treace Medical Concepts, Inc.

NASDAQ · USHealthcareMedical - Devices
$4.23-1.63%

Price as of Jul 20, 2026

TMCI news

Treace Medical Concepts, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)

    SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI) against certain of its officers and directors for alleged breaches of fiduciary duty. Shareholders who have held Treace shares continuously since prior to May 8, 2023, may have standing to seek corporate governance reforms, the return of funds back to the company, and a court-approved incentive award, all

    Globe Newswire ·

  2. Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

    PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its HyperPlate™ XM Dynamic Compression Locking Implant. HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking s

    Globe Newswire ·

  3. Treace to Present at the Sidoti Small Cap Conference

    PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will present at the Sidoti Small Cap Conference, Thursday, June 18, 2026, beginning at approximately 1:45 pm ET. A live webcast and replay of the presentation will be available on the Company’s investors relations website at

    Globe Newswire ·

  4. Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

    SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Treace Medical Concepts, Inc. (NASDAQ: TMCI). The investigation focuses on Treace’s executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased Treace securities? If you purchased Treace securities and suffered losses on your investment, join our investigation now: Click here to join the investigation (https://www.glo

    Globe Newswire ·

  5. Treace Medical Concepts Reports First Quarter 2026 Financial Results

    PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026. Recent Highlights * Generated revenue of $47.2 million in first quarter 2026 compared to $52.6 million in the same period in 2025.  * Reported first quarter 2026 net l

    Globe Newswire ·

  6. Treace to Report First Quarter 2026 Financial Results on May 8, 2026

    PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the first quarter 2026 before the start of trading on Friday, May 8, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Investo

    Globe Newswire ·

  7. Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

    PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first cases utilizing its SuperBite(™) Compression Screw System. SuperBite(™) screws are engineered to deliver advanced compression through a variable thread pitch and optimized headless design,

    Globe Newswire ·

  8. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / March 26, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace Medical securities prior to May 8, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMCI. (h

    ACCESSWIRE ·

  9. Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / March 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace Medical securities prior to May 8, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMCI. (h

    ACCESSWIRE ·

  10. Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / March 12, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace Medical securities prior to May 8, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMCI. (h

    ACCESSWIRE ·

  11. Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

    PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the fourth quarter and full-year ended December 31, 2025. Recent Highlights * Generated revenue of $62.5 million in fourth quarter 2025 and revenue of $212.7 million for the full-year 2025, an increase of 2%

    Globe Newswire ·